Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Concern About Safety of Carotid Angioplasty
Stroke 27:197-198, Beebe,H.G.,et al, 1996
The Residual Cognitive Effects of Heavy Marijiana Use in College Students
Pope. H. G. & Yurgelun-Todd, D. , JAMA 275:521-527, , 1996
Exacerbation of Myasthenia Gravis Associated with Cocaine Use
Neurol 46:271-272, Daras,M.,et al, 1996
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996
Interventional Neuroradiology
BMJ 311:789-792, Taylor,W.&Rodesch,G., 1995
Thrombolytic Therapy in Acute Occlusion of the Intracranial Internal Carotid Artery Bifurcation
AJNR 16:1977-1986, 19941995., Jansen,O.,et al, 1995
Cost-effectiveness of Emergency Intraarterial Intracerebral Thrombolysis:A Pilot Study
AJNR 16:1987-1993, 19941995., Lanzieri,C.F.,et al, 1995
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke:The ECASS
JAMA 274:1017-1025, 10581995., Hacke,W.,et al, 1995
Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995
Randomised Contr Trial of Streptokinase
Aspirin & Comb in Trtm of Acute Ischaemic Stroke, Multictr Acute Stroke Trial-Italy, Lancet 346:1509, 15145,1504,1995., 1995
Clin Features & Pathog of Intracerebral Hemorrhage after rt-PA & Heparin Therapy for Acute Myocardial Infarct
Neurol 45:649-658, Sloan,M.A.,et al, 1995
Does Arterial Recanalization Improve Outcome in Carotid Territory Stroke?
Stroke 26:581-587, vonKummer,R.,et al, 1995
Intraventricular Recombinant Tissue Plasminogen Acivator for Lysis of Intraventricular Haemorrhage
JNNP 58:447-451, Rohde,V.,et al, 1995
Treatment of Dural Sinus Thrombosis Using Selective Catheterization and Urokinase
Ann Neurol 38:58-67, Horowitz,M.,et al, 1995
Thrombolysis and Low Back Pain
BMJ 310:504, Fishwick,D.,et al, 1995
Thrombolytic Treatment for Acute Occlusion of the Basilar Artery
JNNP 58:227-228, Huemer,M.,et al, 1995
Embolic Stroke Following Thrombolytic Therapy for Myocardial Infarction in a Patient with Preexisting Ventricular Thrombi
Stroke 26:324-325, Bautista,R.E.D., 1995
Dural Sinus Thrombosis Complicating Subclavian Vein Catheterization:Treatment with Local Thrombolysis
Pediatrics 95:138-140, Gebara,B.M.,et al, 1995
Guidelines for the Management of Patients with Acute Ischemic Stroke
Stroke 25:1901-1914, Adams,H.P.,et al, 1994
Hirudin in Acute Myocardial Infarction
Circulation 90:1624-1630, 1631, 2147994., Antman,E.M., 1994
Neurologic Manifestations of Cocaine Exposure in Childhood
Pediatrics 93:557-560, Mott,S.H.,et al, 1994
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994
Ancrod for the Treatment of Acute Ischemic Brain Infarction
Stroke 25:1755-1759, Sherman,D.G.,et al, 1994
Intracerebral Hemorrhage Complicating Urokinase Infusion Into an Occluded Aortocoronary Bypass Graft
Cathet Cardiovasc Diagn 31:206-210, Taylor,M.A.,et al, 1994
Evaluation of Risk of Hemorrhagic Transformation in Local Intra-arterial Thrombolysis in Acute Ischemic Stroke by Initial SPECT
Stroke 25:298-303, Ueda,T.,et al, 1994
Factors Related to Intracranial Hematoma in Pts Receiving Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
Stroke 25:291-297, Levy,D.E.,et al, 1994
Prospective Study of Endogenous Tissue Plasminogen Activator and Risk of Stroke
Lancet 343:940-943, Ridker,P.M.,et al, 1994
Chronic Candidal Meningitis: An Uncommon Manifestation of Candidiasis
Clin Inf Dis 19:60-66, Voice, R.A.,et al, 1994
Individual Risk Assessment for Intracranial Haemorrhage During Thrombolytic Therapy
Lancet 342:1523-1528, Simoons,M.L.,et al, 1993
Toluene Abuse Causing Reduced MR Signal Intensity in the Brain
AJR 161:1259-1261, Caldemeyer,K.S.,et al, 1993
Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 24:1439-1446, Overgaard,K.,et al, 1993
Interventional Neurology:A Subspecialty Whose Time Has Come
Neurol 43:2395-2399, Kori,S.H., 1993
Stroke Associated with Ephedrine Use
Neurol 43:1313-1316, Bruno,A.,et al, 1993
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Myocardial Infarction, Thrombolytic Therapy, and Stroke, A Community-Based Study
Stroke 24:587-590, Longstreth,W.T.,et al, 1993
Intracerebral Hemorrhage After Fibrinolytic Therapy for Acute Myocardial Infarction
C. R. , Stroke 24:554-557, 5233., Wijdicks,E.F.M.&Jack,Jr, 1993
Low Back Pain Associated with Anistreplase
BMJ 306:896, Lear,J.&Rajapakse,R., 1993
Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 24:1000-1004, Haley,E.C.,et al, 1993
Use of Benzodiazepines in Anxiety Disorders
NEJM 328:1398-1405, Shader,R.I.&Greenblatt,D.J., 1993
Thrombolysis in Acute Ischemic Stroke:Does it Work
Stroke 23:1826-1839, Wardlaw,J.M.&Warlow,C.P., 1992
Carotid Endarterectomy:Recommendations for Manag of Transient Ischaemic Attack and Ischaemic Stroke
BMJ 305:1071-1074, Brown,M.M.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Delay in P300 Latency in Patients with Organic Solvent Exposure
Arch Neurol 49:315-320, Morrow,L.A.,et al, 1992
Thromboendartectomy of the Symptomatic Occluded Internal Carotid Artery
J Neurosurg 76:752-758, McCormick,P.W.,et al, 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Intrinsic Spinal Cord Haemorrhage Due to Streptokinase Treatment for Myocardial Infarction
JNNP 55:740, Cruickshank,G.S.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992